Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
& Butterfield, D
An accompanying editorial in the same issue of New England Journal of Medicine underlined the importance of the data for the vision of a novel incretin based therapy in diabetes (10)
High glucose availability limits the ability of fatty acids to get inside the mitochondria, so fatty acid oxidation goes down and the mitochondria predominantly oxidize glucose for energy
Kempkes M et al
Nine-year effects of 3.7 years of intensive glycemic control on cardiovascular outcomes
Type 2 Diabetes Accounts for the Largest Share of the GLP-1 Market Based on the target indication, the market is segmented into Alzheimer's Disease, non-alcoholic steatohepatitis, obesity, sleep apnea, and type 2 diabetes
US$ 26.99
US$ 27.52
US$ 24.27
US$ 25.10
US$ 28.73
US$ 21.79
US$ 25.05
